ImmunoPrecise Antibodies (IPA) Institutional Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free IPA Stock Alerts $1.20 -0.02 (-1.64%) (As of 03:25 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.32MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$58.20K Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/29/2024Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 1/31/2023Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022 Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% 10/21/2022Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022 Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% 4/21/2021Ingalls & Snyder LLC517,195$5.08M0.2%+30.5%2.705% 2/19/2021JPMorgan Chase & Co.19,505$292K0.0%N/A0.116% 2/17/2021Jane Street Group LLC40,774$610K0.0%N/A0.243% 2/5/2021Orion Portfolio Solutions LLC15,821$237K0.0%N/A0.094% 1/27/2021Ingalls & Snyder LLC396,425$5.93M0.3%N/A2.358% Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide(Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($2.19M), Bank of Montreal Can ($668K), Ikarian Capital LLC ($237K), Cibc World Market Inc. ($183K), and Gradient Capital Advisors LLC ($107K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($483.55K), Bank of Montreal Can ($275.50K), Cibc World Market Inc. ($47.43K), Rathbones Group PLC ($14K), and Gradient Capital Advisors LLC ($6.81K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 827,290 shares in the last 24 months. This purchase volume represents approximately $2.50M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K), and Ikarian Capital LLC ($16.22K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 48,019 shares in the last 24 months. This volume of shares sold represents approximately $119.82K in transactions. Related Companies: Fortress Biotech Major Shareholders VYNE Therapeutics Major Shareholders JanOne Major Shareholders BriaCell Therapeutics Major Shareholders Theratechnologies Major Shareholders Aprea Therapeutics Major Shareholders ProMIS Neurosciences Major Shareholders CASI Pharmaceuticals Major Shareholders Lexaria Bioscience Major Shareholders Cara Therapeutics Major Shareholders This page (NASDAQ:IPA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
